Advanox (Q3989273): Difference between revisions
Jump to navigation
Jump to search
(Removed claim: country (P32): Kingdom of the Netherlands (Q213)) |
(Changed an Item: Fixing dateand country) |
||||||||||||||
Property / start time | |||||||||||||||
2 January 2018
| |||||||||||||||
Property / start time: 2 January 2018 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / end time | |||||||||||||||
31 December 2019
| |||||||||||||||
Property / end time: 31 December 2019 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / country | |||||||||||||||
Property / country: Netherlands / rank | |||||||||||||||
Normal rank |
Revision as of 10:54, 14 December 2021
Project Q3989273 in Netherlands
Language | Label | Description | Also known as |
---|---|---|---|
English | Advanox |
Project Q3989273 in Netherlands |
Statements
95,280.66 Euro
0 references
544,460.89 Euro
0 references
17.5 percent
0 references
2 January 2018
0 references
31 December 2019
0 references
Jotem BV
0 references
7671SW
0 references
8131 TE
0 references
Identifiers
OP-2014-2023-Oost-PROJ-00817
0 references